PBMs and the Ecosystem of Prescription Drug Benefit Contracting

Lawton Robert Burns ()
Additional contact information
Lawton Robert Burns: The Wharton School, University of Pennsylvania

Chapter Chapter 9 in The Healthcare Value Chain, 2022, pp 365-414 from Springer

Abstract: Abstract Chapters 3 – 8 dealt with the role of GPO intermediariesIntermediaries in the institutional supply chainSupply chain—i.e., the channelsChannels that lead from product manufacturersManufacturers down to the institutions the provide healthcare (e.g., hospitals). These products include medical-surgical supplies, medical devicesMedical devices and other physician preference itemsPhysician preference items (PPIs), and certain types of pharmaceuticalsPharmaceuticals (e.g., drugs that deal with sepsis, large molecule biologics that must be infused)..

Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-031-10739-9_9

Ordering information: This item can be ordered from
http://www.springer.com/9783031107399

DOI: 10.1007/978-3-031-10739-9_9

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().